Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom

Hardly a week passes where we don't learn of some cutting-edge research that helps us better understand our bodies and how to harness them to combat disease. The revolutionary vaccines for COVID-19 have primed society to appreciate those breakthroughs -- and they keep coming.

One unsung hero in the effort is a small company helping facilitate the production of cell and gene therapies called BioLife Solutions (NASDAQ: BLFS). The company is growing quickly and could be a diversified way to profit from amazing discoveries happening in the world of scientific research. That's because it isn't developing its own drugs -- it's helping others do it.

Image source: Getty Images.

Source Fool.com